Jove
Visualize
Contact Us

Related Concept Videos

Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

743
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
743
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

822
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
822
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

786
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
786
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

849
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
849
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.4K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing cognitive impairment in drivers on hemodialysis through reaction time.

Dementia & neuropsychologia·2026
Same author

The Role of Mitochondria in Obstructive Sleep Apnea: Implications for the Upper Airway Muscles.

International journal of molecular sciences·2025
Same author

Brazilian Academy of Neurology practice guidelines for stroke rehabilitation: part I.

Arquivos de neuro-psiquiatria·2022
Same author

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room.

Sao Paulo medical journal = Revista paulista de medicina·2022
Same author

Misdiagnosing restless legs syndrome/Willis-Ekbom disease despite the IRLSSG criteria.

Sleep medicine·2020
Same author

Creating cartoons to represent habitual leg movements.

Arquivos de neuro-psiquiatria·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 18, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

49.6K

Opioids for restless legs syndrome.

César Osório de Oliveira1, Luciane Bc Carvalho, Karla Carlos

  • 1Department of Neurology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

The Cochrane Database of Systematic Reviews
|June 30, 2016
PubMed
Summary

Opioids effectively treat restless legs syndrome (RLS) symptoms and improve quality of life and sleep. However, more research is needed to confirm their safety due to potential adverse events.

More Related Videos

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.7K
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.3K

Related Experiment Videos

Last Updated: Mar 18, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

49.6K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.7K
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.3K

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Trials

Background:

  • Restless Legs Syndrome (RLS) is a common neurological disorder significantly impacting patient quality of life.
  • Current RLS treatments include dopaminergic drugs, anticonvulsants, benzodiazepines, and opioids, with varying efficacy and side effect profiles.
  • Opioids are considered for severe RLS due to shared central nervous system mechanisms with pain, despite known adverse events like constipation and dependence.

Purpose of the Study:

  • To systematically review the efficacy and safety of opioid treatment compared to placebo for adult patients with Restless Legs Syndrome (RLS).
  • To evaluate the impact of opioid therapy on RLS symptom severity, quality of life, and sleep quality.

Main Methods:

  • A systematic review was conducted, searching major databases (Cochrane, MEDLINE, EMBASE, LILACS) for randomized clinical trials (RCTs) up to April 2016.
  • Included were RCTs evaluating opioid treatment versus placebo in adult patients with idiopathic RLS, with no language restrictions.
  • Data extraction and risk of bias assessment were performed independently by two reviewers.

Main Results:

  • One RCT (304 participants) evaluated prolonged-release oxycodone/naloxone versus placebo over 12 weeks.
  • Opioid treatment demonstrated significant improvement in RLS symptoms, quality of life, and sleep quality compared to placebo.
  • Higher rates of adverse events, primarily gastrointestinal issues, fatigue, and headache, were reported in the opioid group.

Conclusions:

  • Opioids appear effective in managing Restless Legs Syndrome (RLS) symptoms, improving patient-reported outcomes.
  • The safety profile of opioids for RLS requires further investigation due to limited data and a high dropout rate in the included study.
  • Moderate quality evidence suggests potential benefits but highlights the need for more robust safety data.